In Vivo Detection of Apoptosis
暂无分享,去创建一个
[1] Bradley D. Smith,et al. New reagents for phosphatidylserine recognition and detection of apoptosis. , 2005, Bioorganic & medicinal chemistry.
[2] K. Linton,et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes , 2005, Nature Cell Biology.
[3] F. Blankenberg,et al. Radioimaging to identify myocardial cell death and probably injury , 2000, The Lancet.
[4] S. Ran,et al. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. , 2002, Cancer research.
[5] G. Nelsestuen,et al. Highly sequential binding of protein kinase C and related proteins to membranes. , 1991, Biochemistry.
[6] S. Orrenius,et al. Apoptosis: molecular mechanisms and implications for human disease , 1995, Journal of internal medicine.
[7] E. Oldfield,et al. Spectroscopic studies of lipids and biological membranes: carbon-13 and proton magic-angle sample-spinning nuclear magnetic resonance study of glycolipid-water systems. , 1992, Biochemistry.
[8] J. Weber,et al. Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV‐I)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) , 2000, Clinical and experimental immunology.
[9] Guido Slegers,et al. Apoptosis-detecting radioligands: current state of the art and future perspectives , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[10] P. Kinnunen,et al. Binding of cationic liposomes to apoptotic cells. , 2004, Analytical biochemistry.
[11] H. Steller. Mechanisms and genes of cellular suicide , 1995, Science.
[12] L. Mortelmans,et al. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] D. Bredesen,et al. Endoplasmic reticulum stress-induced cell death mediated by the proteasome , 2007, Cell Death and Differentiation.
[14] P. Julyan,et al. Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124. , 2005, Nuclear medicine and biology.
[15] R. Aguilar-Quesada,et al. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation. , 2007, Current medicinal chemistry.
[16] M. Lejeune,et al. Prolonged but reversible neutrophil dysfunctions differentially sensitive to granulocyte colony‐stimulating factor in children with acute lymphoblastic leukaemia , 1998, British journal of haematology.
[17] P. Thimister,et al. In vivo detection of cell death in the area at risk in acute myocardial infarction. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] I. Cox,et al. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration , 2004, NMR in biomedicine.
[19] F. Blankenberg,et al. Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. , 1996, Blood.
[20] Akihiro Noda,et al. 18F-labelled annexin V: a PET tracer for apoptosis imaging , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[21] D. Cosgrove,et al. Advances in ultrasound. , 2002, Clinical radiology.
[22] D. Leibfritz,et al. Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. , 1996, Anticancer research.
[23] J. Wu,et al. Apoptosis and angiogenesis: two promising tumor markers in breast cancer (review). , 1996, Anticancer research.
[24] A. Schroit,et al. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.
[25] W. Oyen,et al. Caffeine prevents protection in two human models of ischemic preconditioning. , 2006, Journal of the American College of Cardiology.
[26] C. Reutelingsperger,et al. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. , 2006, Experimental cell research.
[27] R. Weissleder,et al. Optimal Modification of Annexin V with Fluorescent Dyes , 2004, Chembiochem : a European journal of chemical biology.
[28] Michael R. Olson,et al. Mitochondria in apoptosis and human disease. , 2001, Current molecular medicine.
[29] Janet F Eary,et al. Production of [F-18]fluoroannexin for imaging apoptosis with PET. , 2004, Bioconjugate chemistry.
[30] F. Blankenberg. Molecular imaging: The latest generation of contrast agents and tissue characterization techniques , 2003, Journal of cellular biochemistry.
[31] M. Cerqueira,et al. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. , 1995, Circulation.
[32] J. Searle,et al. A suggested explanation for the paradoxically slow growth rate of basal‐cell carcinomas that contain numerous mitotic figures , 1972, The Journal of pathology.
[33] T. Bathen,et al. Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas , 2007, BMC Cancer.
[34] D. Hunting,et al. PET imaging of apoptosis with 64Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[35] V. Dawson,et al. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.
[36] K. Bullok,et al. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. , 2005, Journal of medicinal chemistry.
[37] R. Gonzalez,et al. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. , 1998, Cancer research.
[38] D. Smrz,et al. Non-apoptotic Phosphatidylserine Externalization Induced by Engagement of Glycosylphosphatidylinositol-anchored Proteins* , 2007, Journal of Biological Chemistry.
[39] G. Slegers,et al. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] D. Gibson,et al. Essential Role of B-helix Calcium Binding Sites in Annexin V-Membrane Binding* , 2004, Journal of Biological Chemistry.
[41] F. Blankenberg,et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. , 1997, Blood.
[42] A. Reader,et al. Imaging apoptosis in vivo using 124I-annexin V and PET. , 2005, Nuclear medicine and biology.
[43] Roland Hustinx,et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] C. Reutelingsperger,et al. The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5. , 2004, Analytical biochemistry.
[45] Ralph Weissleder,et al. A fluorescent nanosensor for apoptotic cells. , 2006, Nano letters.
[46] J C Lindon,et al. Biochemical classification of kidney carcinoma biopsy samples using magic-angle-spinning 1H nuclear magnetic resonance spectroscopy. , 1998, Journal of pharmaceutical and biomedical analysis.
[47] I. Ziv,et al. Molecular imaging of cell death in vivo by a novel small molecule probe , 2006, Apoptosis.
[48] H. Strauss,et al. Invited commentary: P.S.* I love you: implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[49] Kuender D Yang,et al. Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks , 2002, Journal of leukocyte biology.
[50] E. Livingston,et al. Screening and detection of apoptosis. , 2007, The Journal of surgical research.
[51] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[52] A. Mackensen,et al. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. , 2006, Blood.
[53] O. Schober,et al. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. , 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[54] J. Hohmann,et al. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. , 2003, European journal of radiology.
[55] D. Feyes,et al. A simplified method for preparation of 99mTc-annexin V and its biologic evaluation for in vivo imaging of apoptosis after photodynamic therapy. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] Ralph Weissleder,et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle , 2005, Magnetic resonance in medicine.
[57] A. W. Boersma,et al. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin. , 1996, Cytometry.
[58] D. Gibson,et al. Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. , 2004, Analytical biochemistry.
[59] J W Hunt,et al. Monitoring structural changes in cells with high-frequency ultrasound signal statistics. , 2005, Ultrasound in medicine & biology.
[60] F. Blankenberg,et al. In vivo imaging of apoptosis in patients with acute stroke: Correlation with blood–brain barrier permeability , 2006, Brain Research.
[61] Shun-dong Ji,et al. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[62] R. Kauppinen,et al. Water diffusion in a rat glioma during ganciclovir‐thymidine kinase gene therapy‐induced programmed cell death in vivo: Correlation with cell density , 2004, Journal of magnetic resonance imaging : JMRI.
[63] D. Gibson,et al. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. , 1994, The Journal of laboratory and clinical medicine.
[64] D. Bredesen,et al. An alternative, nonapoptotic form of programmed cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[65] J. Perlman,et al. Apoptosis and White Matter Injury in Preterm Infants , 2002, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[66] Ralph Weissleder,et al. Magneto/optical annexin V, a multimodal protein. , 2004, Bioconjugate chemistry.
[67] I. Baumann,et al. Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus. , 2003, Immunobiology.
[68] G.,et al. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .
[69] S. Laurent,et al. A New Peptidic Vector for Molecular Imaging of Apoptosis, Identified by Phage Display Technology , 2006, Journal of biomolecular screening.
[70] K. Ellem,et al. John Kerr and apoptosis , 2000, The Medical journal of Australia.
[71] C. Reutelingsperger,et al. Cell Surface-expressed Phosphatidylserine and Annexin A5 Open a Novel Portal of Cell Entry* , 2004, Journal of Biological Chemistry.
[72] C. I. Zeeuw,et al. Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis , 1997, Cell Death and Differentiation.
[73] C. Higgins,et al. Phosphatidylserine exposure in B lymphocytes: a role for lipid packing. , 2006, Blood.
[74] F. Wang,et al. Preparation, in vitro and in vivo evaluation of (99m)Tc-Annexin B1: a novel radioligand for apoptosis imaging. , 2005, Biochemical and biophysical research communications.
[75] A. Wyllie,et al. Cell death in the normal neonatal rat adrenal cortex , 1973, The Journal of pathology.
[76] S. Gürel,et al. Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver‐specific late phase of contrast enhancement with levovist , 2002, Journal of clinical ultrasound : JCU.
[77] P. Comfurius,et al. Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.
[78] A. Schroit,et al. Regulated Externalization of Phosphatidylserine at the Cell Surface , 2007, Journal of Biological Chemistry.
[79] C. Van de Wiele,et al. Intraobserver, interobserver, and day-to-day reproducibility of quantitative 99mTc-HYNIC annexin-V imaging in head and neck carcinoma. , 2004, Cancer biotherapy & radiopharmaceuticals.
[80] J. Ameisen. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years , 2002, Cell Death and Differentiation.
[81] F. Miller,et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. , 2006, Journal of vascular and interventional radiology : JVIR.
[82] J. G. Miller,et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.
[83] P. Thimister,et al. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5. , 2003, The British journal of radiology.
[84] F. Blankenberg,et al. Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia , 2006, Neurology.
[85] F. Blankenberg,et al. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[86] Sophie Martin,et al. Immunologic Stimulation of Mast Cells Leads to the Reversible Exposure of Phosphatidylserine in the Absence of Apoptosis , 2000, International Archives of Allergy and Immunology.
[87] G. Salido,et al. Early caspase‐3 activation independent of apoptosis is required for cellular function , 2006, Journal of cellular physiology.
[88] R. Kauppinen,et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. , 1998, Cancer research.
[89] F. Blankenberg. To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[90] F. Hoebers,et al. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[91] D. von Laer,et al. The influence on the immunomodulatory effects of dying and dead cells of Annexin V , 2007, Journal of leukocyte biology.
[92] M. Vannan,et al. Targeted ultrasound imaging using microbubbles. , 2004, Cardiology clinics.
[93] J. Kerr. History of the events leading to the formulation of the apoptosis concept. , 2002, Toxicology.
[94] F. Blankenberg,et al. 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[95] H. Bartelink,et al. In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. , 2004, International journal of radiation oncology, biology, physics.
[96] W. Oyen,et al. Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans , 2005, Circulation.
[97] W Burchert,et al. Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. , 2003, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[98] F. Blankenberg,et al. 99mTc Annexin V Imaging of Neonatal Hypoxic Brain Injury , 2000, Stroke.
[99] H. Thierens,et al. Biodistribution and dosimetry study of 123I‐rh‐annexin V in mice and humans , 2003, Nuclear medicine communications.
[100] J. Tait,et al. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. , 2006, Nuclear medicine and biology.
[101] R. Scheuermann,et al. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. , 1999, Experimental cell research.
[102] P. Jakob,et al. Assessment of Cardiovascular Apoptosis in the Isolated Rat Heart by Magnetic Resonance Molecular Imaging , 2006, Molecular imaging.
[103] W. Oyen,et al. Oral therapy with dipyridamole limits ischemia‐reperfusion injury in humans , 2005, Clinical pharmacology and therapeutics.
[104] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[105] I. Ziv,et al. Monitoring of Chemotherapy-Induced Cell Death in Melanoma Tumors by N,N′-Didansyl-L-cystine , 2007, Technology in cancer research & treatment.
[106] F. Blankenberg,et al. Structural requirements for in vivo detection of cell death with 99mTc-annexin V. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[107] A. Mayk,et al. Novel molecular imaging of cell death in experimental cerebral stroke , 2007, Brain Research.
[108] Chun Li,et al. The Imaging of Apoptosis with the Radiolabeled annexin V: Optimal Timing for Clinical Feasibility , 2004, Technology in cancer research & treatment.
[109] G. Slegers,et al. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[110] J. Környei,et al. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death. , 2006, Nuclear medicine and biology.
[111] R. Gold,et al. Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models , 1998, Histochemistry and Cell Biology.
[112] K. Fujikawa,et al. Evaluation of annexin V as a platelet-directed thrombus targeting agent. , 1994, Thrombosis research.
[113] F. Blankenberg,et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection , 2001, Nature Medicine.
[114] R. Mach,et al. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. , 2006, Bioorganic & medicinal chemistry letters.
[115] N. deSouza,et al. Diffusion-weighted magnetic resonance imaging and its application to cancer , 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.
[116] K. Maiese,et al. Membrane asymmetry and DNA degradation: functionally distinct determinants of neuronal programmed cell death , 2000, Journal of neuroscience research.
[117] K. Nicolay,et al. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. , 2006, Bioconjugate chemistry.
[118] U. Haberkorn,et al. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone. , 2001, Nuclear medicine and biology.
[119] M. Daemen,et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. , 2004, The New England journal of medicine.
[120] Klaas Nicolay,et al. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. , 2006, Bioconjugate chemistry.
[121] S. Ben‐Sasson,et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.
[122] W. Steers,et al. In vivo detection of apoptotic cells in the testis using fluorescence labeled annexin V in a mouse model of testicular torsion. , 2005, The Journal of urology.
[123] Raphael Pfeffer,et al. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. , 2004, Journal of neurosurgery.
[124] J W Hunt,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0724 Ultrasound imaging of apoptosis: high-resolution noninvasive , 2022 .
[125] Chun Xing Li,et al. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[126] I. Yahara,et al. Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[127] C. Reutelingsperger,et al. Past, present, and future of annexin A5: from protein discovery to clinical applications. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[128] C. Reutelingsperger,et al. The Complexity of the Phospholipid Binding Protein Annexin V , 1995, Thrombosis and Haemostasis.
[129] J. Lindner. Detection of inflamed plaques with contrast ultrasound. , 2002, The American journal of cardiology.